Clinical Genomics Pathology is a biotechnology company providing tests for the detection and monitoring of colorectal cancer. Its products include InSure ONE, a fecal immunochemical test for screening in healthy adults; and Colvera, a blood test identifying circulating tumor DNA in patients post-treatment for early detection of recurrence and residual disease. The company also applies its proprietary technology in molecular pathology to commercialization of diagnostic tools for other cancer types.